PubMed · 1993 · 502 citations · 8 references
Open access
MedicineCell BiologyOncologyMolecular OncologyMolecular PharmacologyProtein BiochemistryCellular Drug EffluxCellular Drug UptakeImmunohistochemistryLysosomal BiochemistryDrug Transporter OverexpressionMonoclonal Antibody SpecificityMultidrug Resistance TransportP-glycoprotein TransportTransporter-mediated Drug ResistanceTransporter-mediated Multidrug Resistance
A M(r) 110,000 protein (p110) is overexpressed in P-glycoprotein-negative multidrug-resistant tumor cell lines of different histogenetic origins. These cell lines show an ATP-dependent drug accumulation defect, suggesting the presence of drug transporter molecules different from P-glycoprotein. Immunohistochemical staining with a p110-specific monoclonal antibody (LRP-56) showed that, like P-glycoprotein, the molecule has a high expression in normal epithelial cells and tissues chronically exposed to xenobiotics and potentially toxic agents, such as bronchial cells, cells lining the intestines, and kidney tubules. Staining of LRP-56 is primarily cytoplasmic, in a coarsely granular fashion, indicating that it reacts with a molecule closely associated with vesicular/lysosomal structures. Involvement of p110 in the energy-dependent drug transport process present in the cell lines is unknown.
8
Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
Susan P.C. Cole, Gabu Bhardwaj, James H. Gerlach et al. · Science · 1992 · 3.1K citations
Hiskias G. Keizer, G.J. Schuurhuis, H J Broxterman et al. · Lung Cancer · 1990 · 121 citations
Medicine, Oncology, Pharmacology +17